Home > Healthcare > Analytical Instruments > Lab Equipment and Supplies > CT/NG Testing Market

CT/NG Testing Market Share

Report ID: GMI9397
Published Date: May 2024
Report Format: PDF

Download Free Sample

CT/NG Testing Market Share

The CT/NG testing industry is characterized by the presence of several established and emerging players that offer a variety of products and services across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

CT/NG Testing Market Companies

Prominent players operating in the CT/NG testing industry include:

Abbott Laboratories
Becton, Dickinson, and Company
binx health, inc.
Bioneer Corporation
Bio-Rad Laboratories, Inc.
Cepheid
ELITech Group
Genetic Signatures
Hologic, Inc.
Meridian Bioscience
Qiagen
Roche
Seegene, Inc.
Thermo Fisher Scientific, Inc.
VIRCELL S.L.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

CT/NG testing market size was USD 1.5 billion in 2023 and is expected to register 7.1% CAGR from 2024-2032 owing to the increasing incidence of sexually transmitted infections (STIs) coupled with growing awareness and screening programs worldwide.

CT/NG testing industry from the consumables segment held 74.9% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to offering convenient, all-in-one solutions for sample collection, processing, and detection.

North America CT/NG testing industry reached USD 533.4 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to advanced healthcare infrastructure, including well-equipped laboratories, healthcare facilities, and diagnostic centers in the region.

binx health, inc., Bioneer Corporation, Bio-Rad Laboratories, Inc., Cepheid, ELITech Group, Genetic Signatures, Hologic, Inc., Meridian Bioscience, Qiagen, Roche, Seegene, Inc., Thermo Fisher Scientific, Inc., and VIRCELL S.L., are some of the major CT/NG testing companies worldwide.